• Facebook
  • X
  • Events
  • News
  • Donate
Search
Hit enter to search or ESC to close
New Jersey Alliance for Clinical and Translational Science New Jersey Alliance for Clinical and Translational Science
  • Home
  • About
    • Mission
    • Membership
    • Affiliated Institutions
    • NJ ACTS Leadership
    • Cite the CTSA and Publications
    • CTSA Resources
    • Elements
  • Community
    • Our Services
    • Community Leadership
    • Volunteering for a Clinical Trial FAQs
    • Find a Clinical Trial
    • Partnership & Innovation Funding Opportunities
    • COVID-19 Resources
  • Investigator Resources
    • Funding Opportunities
    • Biostatistics, Epidemiology, Research Design (BERD)
    • Informatics Services
    • Regulatory Knowledge & Support
    • Special Populations in Research
    • Team Science
    • Genetically informed Research, Education, And Treatment
    • Biomarkers
    • ResearchMatch (RM)
    • Dissemination & Implementation Workgroup
    • COVID-19
    • Additional Resources
  • Education & Training
    • Workforce Development
    • R25 Clinical Research Experiential Summer Training (CREST)
    • Badges
    • Seminars, Workshops, Media Library
    • Learning Health System – STAR
    • Promoting STEM in High School and Earlier
    • Undergraduate Education and Training
    • Beyond Traditional Graduate Courses
    • NJ ACTS Collaborative Graduate Programs
  • K12 & T32
    • K12 Mentored Career Development Awards
    • T32 Predoctoral Training Awards
  • Clinical Trials Office
    • About
    • OnCore
    • Solutions
    • Services
    • Manage Studies
    • Resources
  • Contact Us
    • NJ ACTS Newsletter
Select Page
Access Meets Impact at NJIT, Recognized by Carnegie Classifications.

Access Meets Impact at NJIT, Recognized by Carnegie Classifications.

by William Jester | Apr 30, 2025 | Community, News

Two of New Jersey Institute of Technology’s most distinguishing qualities — its focus on technology and commitment to access — have been recognized by Carnegie Classification. NJIT is among a small and elite group of universities nationally to receive this combination...

Princeton undergraduates gain real-world experience through community health micro-internships.

by William Jester | Apr 29, 2025 | Community, News

Four Princeton undergraduate students — Zoe Tavares, Adrija Kundu, Lena Chau, and Janah Richardson — gave back to communities and gained practical, real-world experience by working with New Jersey-based organizations focused on public health-related projects and...

Are Insulin Resistance Supplements Legit for Weight Loss? Experts Explain How They Work.

by William Jester | Apr 29, 2025 | Community, News

Just like Taylor Swift during her Eras Tour, it seems like weight loss supplements are everywhere right now—and that includes insulin resistance supps. Supplement companies market insulin resistance supplements to help lower your blood sugar, curb glucose spikes,...

Overdose deaths see a historic drop. What’s N.J. doing right?

by William Jester | Apr 28, 2025 | Community, News

Drug overdose deaths in New Jersey dropped across all racial and ethnic groups for the first time in a decade, the New Jersey Department of Health announced Wednesday. New Jersey had 2,816 drug overdose deaths in 2023, down from 3,171 in 2022, with meaningful...

‘People will die based on these decisions’: Trump administration cuts funding for dozens of HIV studies.

by William Jester | Apr 27, 2025 | Community, News

At the end of last week, Dr. Colleen Kelley said she was getting texts about every 10 minutes from colleagues whose HIV-related research grants were being terminated by the federal government. “This is just pure chaos and insanity,” said Kelley, chair of the HIV...
« Older Entries
Next Entries »

Recent Posts

  • Tackling the Silent Threat of Inherited Heart Disease.
  • Join Rutgers Health for the Annual Faculty and Staff Engagement Symposium on 4/21
  • Researchers Develop Cognitive Tool Kit Enabling Early Alzheimer’s Detection in Mandarin Chinese.
  • Join the Clinical Trials Office for a Session on Investigational New Drug (IND) Requirements, 4/17 at 12
  • NJIT, Rutgers, Veterans Affairs Dept. Partner to Mitigate Prosthetic Limb Side Effects.

Archives

  • 2026
    • April
    • March
    • February
    • January
  • 2025
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2024
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2023
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2022
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2021
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2020
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2019
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2018
    • December

Categories

  • Community (2,467)
  • Covid (998)
  • CTO Events (6)
  • News (3,127)
  • Pilots (21)
Rutgers R Block logo graphic

THIS SITE

About

Membership

Community

Investigator Resources

Education & Training

News

Events

Contact

CONTACT US

New Jersey Alliance For Clinical and Translational Science (NJ ACTS)

 


  • Facebook

  • Twitter

  • YouTube

  • LinkedIn

© 2019, New Jersey Alliance for Clinical and Translational Science (NJ ACTS). All rights reserved.| Privacy Policy

Rutgers, The State University of New Jersey, is an equal access/equal opportunity institution. Individuals with disabilities are encouraged to direct suggestions, comments, or complaints concerning any accessibility issues with Rutgers web sites to accessibility@rutgers.edu or complete the Report Accessibility Barrier or Provide Feedback Form.